Stanford University

Showing 761-770 of 1,728 Results

• Marina Glibicky

  Clinical Instructor (Affiliated), School of Medicine - Senior Associate Dean for Medical Student Education
  
• 

  Cameron Glick

  Affiliate, Psychiatry and Behavioral Sciences - Interdisciplinary Brain Sciences
  
• 

  Giancarlo Glick

  Clinical Assistant Professor, Psychiatry and Behavioral Sciences
  

  BioInterested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.
• 

  Ira D Glick

  Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
  

  Current Research and Scholarly InterestsSchizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
• Matthew Glickman

  Lecturer, Graduate School of Business - Other Faculty
  
• Caroline Glidden

  Basic Life Research Scientist, Biology
  
• 

  Leanne C. Glikbarg

  Executive Assistant, Investment Team, Stanford Management Company
  
• Noemie Anne Beatrice Globus

  Affiliate, Physics
  
• 

  Nikki Gloudeman

  Director of Content Strategy, University Communications
  

  Current Role at StanfordDirector of Content Strategy
• 

  Andrew Steven Glover

  Affiliate, Graduate School of Business - Academic Administration